VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
XTNT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
XTNTXtant Medical Holdings, Inc.
$0.38$53M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksXTNTQuarterly Financials

Xtant Medical Holdings, Inc. (XTNT) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Xtant Medical Holdings, Inc. (XTNT) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

XTNT Income Statement

Quarterly statement

XTNT Income Statement

Xtant Medical Holdings, Inc. (XTNT) annual income statement — 18-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue23.03M20.88M32.36M33.26M35.41M32.9M31.51M27.94M29.94M27.87M28.11M25.02M20.23M17.94M15.27M14.46M15.28M12.96M13.97M13.78M
Revenue Growth %-34.96%-36.53%2.68%19.04%18.26%18.05%12.11%11.66%48%55.34%84.07%73%32.43%38.46%9.31%4.97%2.02%3.32%-0.32%-1.71%
Cost of Goods Sold9.7M8.91M14.6M11.26M11.13M12.66M15.49M11.63M11.36M10.57M10.97M9.69M7.77M7.41M6.96M6.57M6.9M5.4M6.28M6.59M
COGS % of Revenue42.12%42.68%45.13%33.87%31.42%38.48%49.15%41.63%37.94%37.93%39.03%38.71%38.42%41.28%45.61%45.4%45.19%41.66%44.92%47.8%
Gross Profit13.33M11.97M17.75M21.99M24.28M20.24M16.02M16.31M18.58M17.3M17.14M15.33M12.46M10.54M8.31M7.9M8.37M7.56M7.7M7.19M
Gross Margin %57.88%57.32%54.87%66.13%68.58%61.52%50.85%58.37%62.06%62.07%60.97%61.29%61.58%58.72%54.39%54.6%54.81%58.34%55.08%52.2%
Gross Profit Growth %-45.11%-40.86%10.8%34.86%30.69%17%-6.49%6.35%49.15%64.22%106.32%94.2%48.78%39.37%7.94%9.8%-11.99%-6.56%-14.34%-22.24%
Operating Expenses22.5M14.89M18.7M19.45M19.66M19.18M17.91M20.08M21.53M20.77M20.94M18.72M13.85M12.11M10.03M9.8M9.67M9.39M9.61M8.64M
OpEx % of Revenue97.69%71.32%57.79%58.49%55.52%58.29%56.82%71.89%71.9%74.52%74.51%74.82%68.46%67.5%65.68%67.74%63.32%72.47%68.76%62.68%
Selling, General & Admin16.8M14.46M18.24M18.82M19.09M18.74M17.38M19.38M20.89M20.25M20.45M18.23M13.67M11.94M9.8M9.57M9.43M9.18M9.46M8.37M
SG&A % of Revenue72.96%69.23%56.37%56.58%53.92%56.94%55.16%69.38%69.77%72.63%72.76%72.86%67.57%66.53%64.17%66.15%61.75%70.82%67.68%60.78%
Research & Development695K435K459K634K566K443K522K701K636K527K492K490K180K174K232K229K241K213K151K262K
R&D % of Revenue3.02%2.08%1.42%1.91%1.6%1.35%1.66%2.51%2.12%1.89%1.75%1.96%0.89%0.97%1.52%1.58%1.58%1.64%1.08%1.9%
Other Operating Expenses1000K0000000000000000000
Operating Income-9.17M-2.92M-944K2.54M4.62M1.06M-1.88M-3.78M-2.95M-3.47M-3.81M-3.38M-1.39M-1.58M-1.72M-1.9M-1.3M-1.83M-1.91M-1.45M
Operating Margin %-39.81%-14%-2.92%7.64%13.06%3.23%-5.97%-13.52%-9.84%-12.45%-13.54%-13.53%-6.88%-8.78%-11.29%-13.14%-8.51%-14.13%-13.68%-10.49%
Operating Income Growth %-298.29%-374.98%49.84%167.28%256.96%130.63%50.55%-11.58%-111.79%-120.18%-120.77%-78.16%-7%13.93%9.79%-31.49%-164.77%-36520%-896.25%-290.13%
EBITDA-8.66M-2.39M875K3.7M5.79M2.14M-734K-2.7M-1.95M-2.46M-2.79M-2.5M-588K-1.1M-1.4M-1.53M-982K-1.55M-1.62M-1.14M
EBITDA Margin %-37.61%-11.44%2.7%11.13%16.36%6.49%-2.33%-9.68%-6.51%-8.84%-9.92%-10%-2.91%-6.15%-9.17%-10.57%-6.43%-11.96%-11.6%-8.24%
EBITDA Growth %-249.51%-211.79%219.21%236.91%397.38%186.69%73.68%-8.07%-231.29%-123.48%-99.07%-63.74%40.12%28.84%13.52%-34.63%-638.35%-515.55%-345.08%-189.72%
D&A (Non-Cash Add-back)508K534K1.82M1.16M1.17M1.07M1.15M1.07M998K1M1.02M883K803K473K323K372K318K281K291K310K
EBIT-8.8M-2.46M2.32M2.47M4.81M1.08M-2.01M-3.76M-2.83M-3.5M-2.91M7.69M-1.39M-1.49M-1.69M-1.9M-1.3M-1.83M-1.91M-1.45M
Net Interest Income-541K-380K-624K-904K-1M-1.04M-1.13M-1.2M-992K-835K-802K-712K-786K-489K-464K-440K-397K-359K-466K-329K
Interest Income1K219K94K000000016K48K086K31K00000
Interest Expense542K599K718K904K1M1.04M1.13M1.2M992K835K818K760K786K575K495K440K397K359K466K329K
Other Income/Expense-171K-139K2.54M-976K-819K-1.03M-1.26M-1.19M-879K-862K80K10.32M-786K-489K-464K-440K-397K-359K-466K-329K
Pretax Income-9.34M-3.06M1.6M1.56M3.81M33K-3.14M-4.96M-3.83M-4.33M-3.73M6.93M-2.18M-2.06M-2.19M-2.34M-1.7M-2.19M-2.38M-1.77M
Pretax Margin %-40.55%-14.66%4.94%4.71%10.75%0.1%-9.98%-17.76%-12.77%-15.54%-13.26%27.7%-10.76%-11.51%-14.33%-16.18%-11.11%-16.9%-17.02%-12.88%
Income Tax73K27K1.54M257K255K-25K21K62K36K68K577K-2.3M13K13K21K13K13K23K-94K30K
Effective Tax Rate %-0.78%-0.88%96.43%16.42%6.7%-75.76%-0.67%-1.25%-0.94%-1.57%-15.49%-33.18%-0.6%-0.63%-0.96%-0.56%-0.77%-1.05%3.95%-1.69%
Net Income-9.41M-3.09M57K1.31M3.55M58K-3.17M-5.02M-3.86M-4.4M-4.3M9.23M-2.19M-2.08M-2.21M-2.35M-1.71M-2.21M-2.28M-1.8M
Net Margin %-40.87%-14.79%0.18%3.93%10.03%0.18%-10.04%-17.98%-12.89%-15.79%-15.31%36.9%-10.82%-11.58%-14.47%-16.27%-11.19%-17.08%-16.34%-13.09%
Net Income Growth %-365.15%-5425.86%101.8%126.04%191.95%101.32%26.45%-154.43%-76.3%-111.74%-94.79%492.31%-28.07%6.1%3.24%-30.43%-133.29%-7531.03%-223.37%-32.65%
Net Income (Continuing)-9.41M-3.09M57K1.31M3.55M58K-3.17M-5.02M-3.86M-4.4M-4.3M9.23M-2.19M-2.08M-2.21M-2.35M-1.71M-2.21M-2.28M-1.8M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.07-0.020.000.010.020.00-0.02-0.04-0.03-0.03-0.030.07-0.02-0.02-0.02-0.03-0.02-0.03-0.03-0.02
EPS Growth %-392.89%-101.75%123.66%180.74%101.18%31.12%-154.71%-48%-76.96%-62.25%369.84%-2.04%24.8%32%-26%--11.5%80%
EPS (Basic)-0.07-0.020.000.010.030.00-0.02-0.04-0.03-0.03-0.030.07-0.02-0.02-0.02-0.03-0.02-0.03-0.03-0.02
Diluted Shares Outstanding140.26M150.46M150.46M148.57M148.57M143.34M138.98M135.1M130.27M130.2M130.02M135.66M108.9M108.89M108.34M93.28M87.31M87.19M87.03M86.76M
Basic Shares Outstanding140.26M139.83M139.83M139.31M139.31M143.56M138.98M135.1M130.27M130.2M130.02M128.14M108.9M108.89M108.34M93.28M85.5M87.19M87.03M86.76M
Dividend Payout Ratio--------------------